We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$331M
Cap. Flow %
-8.17%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGTY
476
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.74M 0.04%
156,804
-199,863
-56% -$2.18M
OPY icon
477
Oppenheimer Holdings
OPY
$1.22B
$1.72M 0.04%
+26,783
New +$1.55M
TLN
478
Talen Energy Corp
TLN
$16.2B
$1.72M 0.04%
8,516
+6,516
+326% +$1.27M
RCUS icon
479
Arcus Biosciences
RCUS
$3.56B
$1.71M 0.04%
114,545
-112,026
-49% -$1.83M
VST icon
480
Vistra
VST
$47.7B
$1.7M 0.04%
12,363
+3,307
+37% +$459K
UTI icon
481
Universal Technical Institute
UTI
$1.53B
$1.7M 0.04%
66,162
+27,276
+70% +$568K
DISTW
482
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$1.7M 0.04%
151,200
LYTS icon
483
LSI Industries
LYTS
$913M
$1.69M 0.04%
87,241
-1,725
-2% -$32K
ONC
484
CALL
BeOne Medicines Ltd
ONC
$36.7B
$1.68M 0.04%
9,100
CXM icon
485
Sprinklr
CXM
$1.55B
$1.68M 0.04%
198,909
+14,852
+8% +$119K
WBD icon
486
CALL
Warner Bros
WBD
$66.2B
$1.66M 0.04%
+157,000
New +$1.46M
VRNS icon
487
Varonis Systems
VRNS
$4.87B
$1.64M 0.04%
36,893
+5,306
+17% +$276K
BBIO icon
488
BridgeBio Pharma
BBIO
$16.2B
$1.62M 0.04%
59,029
-19,122
-24% -$494K
AKRO
489
PUT
DELISTED
Akero Therapeutics
AKRO
$1.62M 0.04%
58,200
+100
+0.2% +$3.03K
APP icon
490
Applovin
APP
$113B
$1.62M 0.04%
4,999
-3,691
-42% -$934K
DRUG
491
Bright Minds Biosciences
DRUG
$793M
$1.61M 0.04%
+44,580
New +$1.57M
CPRX
492
DELISTED
Catalyst Pharmaceutical
CPRX
$1.6M 0.04%
76,865
-29,362
-28% -$631K
STRL icon
493
Sterling Infrastructure
STRL
$16.4B
$1.59M 0.04%
9,438
-5,414
-36% -$935K
RDDT icon
494
Reddit
RDDT
$29B
$1.59M 0.04%
9,702
-17,030
-64% -$2.1M
ZM icon
495
Zoom
ZM
$29.7B
$1.58M 0.04%
19,391
-8,585
-31% -$675K
QNST icon
496
QuinStreet
QNST
$874M
$1.57M 0.04%
68,162
+56,946
+508% +$1.2M
DH icon
497
Definitive Healthcare
DH
$72.3M
$1.57M 0.04%
382,525
-341,971
-47% -$1.5M
EPAM icon
498
EPAM Systems
EPAM
$4.86B
$1.57M 0.04%
+6,722
New +$1.5M
KOD icon
499
Kodiak Sciences
KOD
$2.84B
$1.57M 0.04%
157,858
+28,420
+22% +$163K
OS
500
DELISTED
OneStream Inc
OS
$1.57M 0.04%
55,000
+27,500
+100% +$844K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $331M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.